⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10645290 | 0.83 | — | — | |
| SCHEMBL26134035 | 0.71 | MEN1 (0.37) | — | |
| SCHEMBL2501547 | 0.71 | — | — | |
| SCHEMBL2764073 | 0.71 | MEN1 (0.37) | — | |
| SCHEMBL5421494 | 0.71 | — | — | |
| SCHEMBL7878693 | 0.71 | — | — | |
| SCHEMBL27741017 | 0.71 | LMNA (0.37) | — | |
| SCHEMBL8977405 | 0.71 | — | — | |
| SCHEMBL22321698 | 0.69 | DPP4 (0.38) | — | |
| SCHEMBL8832405 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112972683-A | Locally administered medicinal composition of gellinzomib and the like | 刘力 | 2021-06-18 | — | — | CN | claimed |
| CN-112933075-A | Topical administration of kudzu root related pharmaceutical compositions | 刘力 | 2021-06-11 | — | — | CN | claimed |
| CN-112972683-A | Locally administered medicinal composition of gellinzomib and the like | 刘力 | 2021-06-18 | — | — | CN | disclosed |
| CN-112933075-A | Topical administration of kudzu root related pharmaceutical compositions | 刘力 | 2021-06-11 | — | — | CN | disclosed |
| CN-111100122-A | Novel levo-tetrahydropalmatine compound | 刘力 | 2020-05-05 | — | — | CN | disclosed |
| CN-110882271-A | Novel double-calcium pharmaceutical composition | 刘力 | 2020-03-17 | — | — | CN | disclosed |
| US-8629178-B2 | Sodium tanshinone IIA sulfonate hydrate and preparation method and use thereof | LIU LI (CN) | 2014-01-14 | — | — | US | disclosed |
| US-20130280814-A1 | METHOD AND KIT FOR PROTEIN LABELING | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2013-10-24 | — | — | US | disclosed |
| EP-2576589-A1 | METHOD AND KIT FOR PROTEIN LABELING | GE Healthcare Bio-Sciences AB (SE) | 2013-04-10 | — | — | EP | disclosed |
| US-20120277304-A1 | SODIUM TRANSHINONE IIA SULFONATE HYDRATE AND PREPARATION METHOD AND USE THEREOF | LIU LI (CN) | 2012-11-01 | — | — | US | disclosed |
| WO-2011149415-A1 | METHOD AND KIT FOR PROTEIN LABELING | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2011-12-01 | — | — | WO | disclosed |
| US-8063245-B2 | Phosphazene compound, photosensitive resin composition and use thereof | KANEKA CORPORATION (JP) | 2011-11-22 | — | — | US | disclosed |
| US-20060199920-A1 | Photosensitive resin composition capable of being developed with aqueous developer and photosensitive dry film resist, and use thereof | KANEKA CORPORATION (JP) | 2006-09-07 | — | — | US | disclosed |
| US-20060142542-A1 | Phosphazene compound, photosensitive resin composition and use thereof | KANEKA CORPORATION (JP) | 2006-06-29 | — | — | US | disclosed |